Herbs (Global Traditional) · Southeast Asian
Vishnukranthi (Evolvulus alsinoides) (Evolvulus alsinoides)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Vishnukranthi (Evolvulus alsinoides) is a traditional Siddha medicine herb containing flavonoids and alkaloids that enhances memory through acetylcholinesterase inhibition. The plant demonstrates significant nootropic and anti-anxiety effects in preclinical studies, supporting its traditional use as a brain tonic.
Vishnukranthi (Evolvulus alsinoides) is a perennial prostrate herb from the Convolvulaceae family, native to East Asia and used globally in traditional medicine systems. The whole plant, including its oblong-elliptic leaves and small blue flowers, is harvested and processed into methanolic or aqueous extracts, powders (churna), or decoctions (kwath).
Clinical evidence for Vishnukranthi is limited to preclinical animal and in-vitro studies, with no published human clinical trials, RCTs, or meta-analyses available. The available research consists primarily of animal models demonstrating nootropic and anxiolytic effects, but lacks human data, specific sample sizes, or detailed study designs.
Traditional dosages include whole plant powder (churna) at 3-6 g/day divided into two doses with warm water or honey. Decoction (kwath) uses 50 g dried aerial parts boiled in 500 ml water reduced to 150 ml, taken as 50 ml twice daily. Alcoholic tincture standardized to 1% scopoletin at 2-4 ml twice daily. Consult a healthcare provider before starting any new supplement.
Vishnukranthi (Evolvulus alsinoides) is a medicinal herb rather than a dietary staple, so nutritional macronutrient content is minimal and not clinically significant. Key bioactive compounds drive its functional value: **Alkaloids:** Evolvine, betaine (~0.1–0.5% dry weight); contribute to cholinergic modulation and nootropic activity. **Flavonoids:** Kaempferol and quercetin (combined estimated 0.3–1.2% dry weight); potent antioxidants with moderate oral bioavailability (~20–50% for quercetin with food matrix influence; kaempferol slightly lower ~15–40%). **Triterpenoids/Sterols:** Beta-sitosterol and phytosterols (~0.1–0.4% dry weight); anti-inflammatory contributions with low but measurable GI absorption (~5–15%). **Scopoletin (coumarin):** Trace levels (~0.05–0.2% dry weight); associated with acetylcholinesterase inhibitory activity; lipophilic, moderate bioavailability. **Tannins and Phenolic acids:** Gallic acid and ellagic acid derivatives (~0.5–2.0% dry weight); antioxidant and neuroprotective synergy; bioavailability variable (10–30%), enhanced by microbial metabolism. **Essential amino acids:** Present in minor quantities; not a meaningful dietary protein source. **Minerals:** Traces of iron, calcium, and zinc detected in leaf ash analysis; concentrations nutritionally negligible. **Macronutrients (dried herb, approximate per 100g):** Carbohydrates ~55–65g, Crude fiber ~15–20g, Protein ~8–12g, Fat ~2–4g; caloric contribution irrelevant given typical therapeutic dose (1–3g herb/day). **Bioavailability Notes:** Aqueous and hydroalcoholic extracts significantly enhance flavonoid and alkaloid extraction efficiency compared to raw herb; fat-soluble compounds (beta-sitosterol, scopoletin) show improved absorption when taken with lipid-containing meals; tannin content may moderately inhibit mineral co-absorption.
Vishnukranthi exerts neuroprotective effects primarily through acetylcholinesterase inhibition, preventing the breakdown of acetylcholine and enhancing cholinergic neurotransmission. The flavonoids and alkaloids in the plant modulate GABAergic pathways to produce anxiolytic effects. These compounds also protect against scopolamine-induced memory impairment by maintaining cholinergic function in the hippocampus.
Current evidence for Vishnukranthi is limited to animal studies and traditional use documentation. Animal models show memory enhancement effects against scopolamine-induced impairment, with aqueous methanol extracts demonstrating anti-anxiety activity at 100-200 mg/kg dosages. The acetylcholinesterase inhibitory activity has been confirmed in vitro, supporting the traditional nootropic applications. Human clinical trials are needed to establish therapeutic efficacy and optimal dosing protocols.
Safety data for Vishnukranthi is limited, with most information derived from traditional use patterns rather than systematic toxicological studies. The herb may potentially interact with cholinesterase inhibitor medications due to its acetylcholinesterase inhibitory activity. Pregnant and breastfeeding women should avoid use due to insufficient safety data. Individuals taking medications for dementia or anxiety disorders should consult healthcare providers before use.
